Sandia biochemist and virologist are conducting research using CRISPR-based technology to genetically engineer a deployable antiviral countermeasure for COVID- 19.
Their goal is to create an antiviral that will be customizable to respond to many different viruses, including coronavirus. Original public domain image from Flickr
Public DomainFree U.S. Government Image
Say thanks by supporting these good causes